Effect of fish oil on LDL oxidation and plasma homocysteine concentrations in health

Journal of Laboratory and Clinical Medicine

Volumn 141, Issue 1, 2003, Pages 41-49

  Piolot, Alain ^a   Blache, Denis ^a   Boulet, Lucie ^a   Fortin, Louis Jacques ^a   Dubreuil, Denise ^a   Marcoux, Caroline ^a   Davignon, Jean ^a   Lussier Cacan, Suzanne ^a,b  

^a UNIVERSITÉ DE BOURGOGNE   (France)

^b CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0037225154     PISSN: 00222143     EISSN: None     Source Type: Journal    
DOI: 10.1067/mlc.2003.3     Document Type: Article

References (58)

1. Angerer P, Von Schacky C. n-3 polyunsaturated fatty acids and the cardiovascular system. Curr Opin Lipidol 2000;11:57-63.
2. Nestel PJ. Fish oil and cardiovascular disease: lipids and arterial function. Am J Clin Nutr 2000;71:228S-31.
3. Mori TA, Beilin LJ. Long-chain omega 3 fatty acids, blood lipids and cardiovascular risk reduction. Curr Opin Lipidol 2001;12:11-7.
4. Kromhout D, Feskens EJM, Bowles CH. The protective effect of a small amount of fish on coronary heart disease mortality in an elderly population. Int J Epidemiol 1995;24:340-5.
5. Vollset SE, Heuch I, Bjelke E. Fish consumption and mortality from coronary heart disease. N Engl J Med 1985;313:820-1.
6. Curb JD, Reed DM. Fish consumption and mortality from coronary heart disease. N Engl J Med 1985;313:821-2.
7. Ascherio A, Rimm EB, Stampfer MJ, Giovannucci EL, Willett WC. Dietary intake of marine n-3 fatty acids, fish intake, and the risk of coronary disease among men. N Engl J Med 1995;332:977-82.
8. Marckmann P, Gronbaek M. Fish consumption and coronary heart disease mortality: A systematic review of prospective cohort studies. Eur J Clin Nutr 1999;53:585-90.
9. Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL. Beyond cholesterol: modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med 1989;320:915-24.
10. Berliner JA, Heinecke JW. The role of oxidized lipoproteins in atherogenesis. Free Radic Biol Med 1996;20:707-27.
11. Chisolm GM, Steinberg D. The oxidative modification hypothesis of atherogenesis: an overview. Free Radic Biol Med 2000;28:1815-26.
12. Kontush A, Hübner C, Finckh B, Kohlschütter A, Beisiegel U. How different constituents of low density lipoprotein determine its oxidizability by copper: a correlational approach. Free Radic Res 1996;24:135-47.
13. Kleinveld HA, Naber AHJ, Stalenhoef AFH, Demacker PNM. Oxidation resistance, oxidation rate, and extent of oxidation of human low-density lipoprotein depend on the ratio of oleic acid content to linoleic acid content: studies in vitamin E deficient subjects. Free Radic Biol Med 1993;15:273-80.
14. Reaven P, Parthasarathy S, Grasse BJ, Miller E, Steinberg D, Witztum JL. Effects of oleate-rich and linoleate-rich diets on the susceptibility of low density lipoprotein to oxidative modification in mildly hypercholesterolemic subjects. J Clin Invest 1993;91:668-76.
15. Thomas MJ, Thornburg T, Manning J, Hooper K, Rudel LL. Fatty acid composition of low-density lipoprotein influences its susceptibility to autoxidation. Biochemistry 1994;33:1828-34.
16. Parthasarathy S. Oxidation of low-density lipoprotein by thiol compounds leads to its recognition by the acetyl LDL receptor. Biochim Biophys Acta 1987;917:337-40.
17. Heinecke JW, Kawamura M, Suzuki L, Chait A. Oxidation of low density lipoprotein by thiols: superoxide-dependent and -independent mechanisms. J Lipid Res 1993;34:2051-61.
18. Blache D, Rodriguez C, Davignon J. Enhanced susceptibility of cholesteryl sulfate-enriched low density lipoproteins to copper-mediated oxidation. FEBS Lett 1995;362:197-200.
19. Durand P, Prost M, Loreau N, Lussier-Cacan S, Blache D. Impaired homocysteine metabolism and atherothrombotic disease. Lab Invest 2001;81:645-72.
20. Lussier-Cacan S, Dubreuil-Quidoz S, Roederer G, Leboeuf N, Boulet L, De Langavant GC, et al. Influence of probucol on enhanced LDL oxidation after fish oil treatment of hypertriglyceridemic patients. Arterioscler Thromb 1993;13:1790-7.
21. Lussier-Cacan S, Fortin LJ, Dallongeville J, Davignon J. Effect of fish oil supplementation on plasma homocysteine levels in patients with type III and type IV hypertriglyceridemia [abstract]. Atherosclerosis 1994:109(suppl):147.
22. Harris WS, Windsor SL, Dujovne CA. Effects of four doses of n-3 fatty acids given to hyperlipidemic patients for six months. J Am Coll Nutr 1991;10:220-7.
23. Lipid Research Clinics Program. Manual of Laboratory Operations, vol 1: Lipid and lipoprotein analysis. Washington, DC: US Dept of Health, Education and Welfare, 1974.
24. Morrison WR, Smith LM. Preparation of fatty acid methyl esters and dimethylacetals from lipids with boron fluoride-methanol. J Lipid Res 1964;5:600-8.
25. Quintanilha AT, Packer L, Davies JM, Racanelli TL, Davies KJ. Membrane effects of vitamin E deficiency: bioenergetic and surface charge density studies of skeletal muscle and liver mitochondria. Ann N Y Acad Sci 1982;393:32-47.
26. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the folin phenol reagent. J Biol Chem 1951;193:265-75.
27. Esterbauer H, Striegl G, Puhl H, Rotheneder M. Continuous monitoring of in vitro oxidation of human low density lipoprotein. Free Radic Res Commun 1989;6:67-75.
28. Thurnham DI, Smith E, Flora PS. Concurrent liquid-chromatographic assay of retinol, alpha-tocopherol, beta-carotene, alpha-carotene, lycopene, and beta cryptoxanthin in plasma with tocopherol acetate as internal standard. Clin Chem 1988;34:377-81.
29. Bieri JG, Brown ED, Smith JC Jr. Determination of individual carotenoids in human plasma by high performance liquid chromatography. J Liquid Chromatogr 1985;8:473-84.
30. Durand P, Fortin LJ, Lussier-Cacan S, Davignon J, Blache D. Hyperhomocysteinemia induced by folic acid deficiency and methionine load: applications of a modified HPLC method. Clin Chim Acta 1996;252:83-93.
31. Neter J, Wasserman W, Kutner MH. Applied linear statistical models. Boston: Irwin, 1990.
32. Harris WS. n-3 Fatty acids and serum lipoproteins: human studies. Am J Clin Nutr 1997:65(suppl 5):1645S-54.
33. Nenseter MS, Drevon CA. Dietary polyunsaturates and peroxidation of low density lipoprotein. Curr Opin Lipidol 1996;7:8-13.
34. Mabile L, Piolot A, Boulet L, Fortin LJ, Doyle N, Rodriguez C, et al. Moderate intake of n-3 fatty acids is associated with stable erythrocyte resistance to oxidative stress in hypertriglyceridemic subjects. Am J Clin Nutr 2001;74:449-56.
35. Haglund O, Hamfelt A, Hambraeus L, Saldeen T. Effects of fish oil supplemented with pyridoxine and folic acid on homocysteine, atherogenic index, fibrinogen and plasminogen activator inhibitor-1 in man. Nutr Res 1993;13:1351-65.
36. Haglund O, Wallin R, Wretling S, Hultberg B, Saldeen T. Effects of fish oil alone and combined with long chain (n-6) fatty acids on some coronary risk factors in male subjects. J Nutr Biochem 1998;9:629-35.
37. Brude IR, Finstad HS, Seljeflot I, Drevon CA, Solvall K, Sandstad B, et al. Plasma homocysteine concentration related to diet, endothelial function and mononuclear cell gene expression among male hyperlipidaemic smokers. Eur J Clin Invest 1999;29:100-8.
38. Grundt H, Nilsen DW, Hetland O, Mansoor MA, Aarsland T, Woie L. Atherothrombogenic risk modulation by n-3 fatty acids was not associated with changes in homocysteine in subjects with combined hyperlipidaemia. Thromb Haemost 1999;81:561-5.
39. Holdt B, Korten G, Knippel M, Lehmann JK, Claus R, Holtz M, et al. Increased serum level of total homocysteine in CAPD patients despite fish oil therapy. Perit Dial Int 1996;16(suppl 1):S246-9.
40. Olszewski AJ, McCully KS. Fish oil decreases serum homocysteine in hyperlipemic men. Coronary Artery Dis 1993;4:53-60.
41. Selhub J, Miller JW. The pathogenesis of homocysteinemia: interruption of the coordinate regulation by S-adenosylmethionine of the remethylation and transsulfuration of homocysteine. Am J Clin Nutr 1992;55:131-8.
42. Lussier-Cacan S, Xhignesse M, Piolot A, Selhub J, Davignon J, Genest J, Jr. Plasma total homocysteine in healthy subjects: sex-specific relation with biological traits. Am J Clin Nutr 1996;64:587-93.
43. McVeigh GE, Brennan GM, Johnston GD, McDermott BJ, McGrath LT, Henry WR, et al. Dietary fish oil augments nitric oxide production or release in patients with Type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 1993;36:33-8.
44. Renier G, Skamene E, DeSanctis J, Radzioch D. Dietary n-3 polyunsaturated fatty acids prevent the development of atherosclerotic lesions in mice: modulation of macrophage secretory activities. Arterioscler Thromb 1993;13:1515-24.
45. Chaet MS, Garcia VF, Arya G, Ziegler MM. Dietary fish oil enhances macrophage production of nitric oxide. J Surg Res 1994;57:65-8.
46. Harris WS, Rambjor GS, Windsor SL, Diederich D. n-3 fatty acids and urinary excretion of nitric oxide metabolites in humans. Am J Clin Nutr 1997;65:459-64.
47. Okuda Y, Kawashima K, Sawada T, Tsurumaru K, Asano M, Suzuki S, et al. Eicosapentaenoic acid enhances nitric oxide production by cultured human endothelial cells. Biochem Biophys Res Commun 1997;232:487-91.
48. Hirafuji M, Ebihara T, Kawahara F, Minami M. Effect of docosahexaenoic acid on smooth muscle cell functions. Life Sci 1998;62:1689-93.
49. Jeyarajah DR, Kielar M, Penfield J, Lu CY. Docosahexaenoic acid, a component of fish oil, inhibits nitric oxide production in vitro. J Surg Res 1999;83:147-50.
50. Stamler JS, Osborne JA, Jaraki O, Rabbani LE, Mullins M, Singel D, et al. Adverse vascular effects of homocysteine are modulated by endothelium-derived relaxing factor and related oxides of nitrogen. J Clin Invest 1993;91:308-18.
51. Tawakol A, Omland T, Gerhard M, Wu JT, Creager MA. Hyperhomocyst(e)inemia is associated with impaired endothelium-dependent vasodilation in humans. Circulation 1997;95:1119-21.
52. Upchurch GR Jr, Welch GN, Fabian AJ, Freedman JE, Johnson JL, Keany JF Jr, et al. Homocyst(e)ine decreases bioavailable nitric oxide by a mechanism involving glutathione peroxidase. J Biol Chem 1997;272:17012-7.
53. Ikeda U, Ikeda M, Minota S, Shimada K. Homocysteine increases nitric oxide synthesis in cytokine-stimulated vascular smooth muscle cells. Circulation 1999;99:1230-5.
54. Kim WK. S-nitrosation ameliorates homocysteine-induced neurotoxicity and calcium responses in primary culture of rat cortical neurons. Neurosci Lett 1999;265:99-102.
55. Nicolaou A, Kenyon SH, Gibbons JM, Ast T, Gibbons WA. In vitro inactivation of mammalian methionine synthase by nitric oxide. Eur J Clin Invest 1996;26:167-70.
56. Nicolaou A, Waterfield CJ, Kenyon SH, Gibbons WA. The inactivation of methionine synthase in isolated rat hepatocytes by sodium nitroprusside. Eur J Biochem 1997;244:876-82.
57. Brouwer M, Chamulitrat W, Ferruzzi G, Sauls DL, Weinberg JB. Nitric oxide interactions with cobalamins: biochemical and functional consequences. Blood 1996;88:1857-64.
58. Danishpajooh IO, Gudi T, Chen Y, Kharitonov VG, Sharma VS, Boss GR. Nitric oxide inhibits methionine synthase activity in vivo and disrupts carbon flow through the folate pathway. J Biol Chem 2001;276:27296-303.